LAZERTINIB vs LENACAPAVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAZERTINIB vs LENACAPAVIR: Safety Overview
| Metric | LAZERTINIB | LENACAPAVIR |
|---|---|---|
| Total FAERS Reports | 352 | 502 |
| Deaths Reported | 15 | 32 |
| Death Rate | 4.3% | 6.4% |
| Hospitalizations | 83 | 42 |
| Average Patient Age | 66.6 yrs | 50.0 yrs |
| % Female Patients | 59.9% | 24.7% |
| FDA Approval Date | Aug 19, 2024 | Dec 22, 2022 |
| Manufacturer | Janssen Biotech, Inc. | Gilead Sciences, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |